Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters

Abstract Background Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and hormonal disorder in women. This study aimed to assess the effect of maternal PCOS on screening of aneuploidy in the first and second-trimesters. Methods This case-control study was conducted in Arash Hos...

Full description

Bibliographic Details
Main Authors: Narjes Hassan Haivadi, Shahideh Jahanian Sadatmahalleh, Fatemeh Razavinia, Sarang Younesi, Malihe Nasiri, Saeideh Ziaei
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Ovarian Research
Subjects:
Online Access:https://doi.org/10.1186/s13048-023-01251-w
_version_ 1797557228869255168
author Narjes Hassan Haivadi
Shahideh Jahanian Sadatmahalleh
Fatemeh Razavinia
Sarang Younesi
Malihe Nasiri
Saeideh Ziaei
author_facet Narjes Hassan Haivadi
Shahideh Jahanian Sadatmahalleh
Fatemeh Razavinia
Sarang Younesi
Malihe Nasiri
Saeideh Ziaei
author_sort Narjes Hassan Haivadi
collection DOAJ
description Abstract Background Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and hormonal disorder in women. This study aimed to assess the effect of maternal PCOS on screening of aneuploidy in the first and second-trimesters. Methods This case-control study was conducted in Arash Hospital and Nilou Laboratory in 2017–2018. The screening test was conducted on 90 PCOS and 90 healthy mothers. Finally, the first and second-trimester screening was compared between the two groups using Chi-square, Mann-Whitney’s U and students T tests and regression model by SPSS 21. P < 0.05 was considered as statistically significant. Results Free Beta-Human Chorionic Gonadotropin (Free-β-HCG) (P = 0.04), inhibin-A (P = 0.001) and Alpha Fetoprotein (AFP) (P = 0.02) levels were higher in the PCOS women comparing to the healthy women but there was no significant difference between the mean of HCG, Plasma Protein A (PAPP-A), and Unconjugated Estriol (UE3) between the two groups. Pre-eclampsia (P < 0.001) and trisomy 18 risks in quad screening were higher in the PCOS women (P = 0.002) than the control group; however, trisomy 13, trisomy 18 and trisomy 21 risks, Smith-Lemli-Opitz Syndrome (SLOS) and Neural Tube Defect (NTD) risks were not different between the two groups. The logistic regression model showed that the first- and second-trimester screening of aneuploidywas related to PCOS. Conclusions There was a significant difference in the mean of free-β-HCG, inhibin-A, AFP level, and the risks of pre-eclampsia, SLOS and trisomy 18 between the two groups but no significant association was found in the mean of HCG, PAPP-A, UE3, NTD and other aneuploidies between the two groups. PCOS may affect the first- and second-trimester screening tests and pregnancy health. It may also require correction in the calculation of risks related to the first- and second-trimester screening for aneuploidy.
first_indexed 2024-03-10T17:15:30Z
format Article
id doaj.art-a46322bce85a47af9cadaa4ee4c2781e
institution Directory Open Access Journal
issn 1757-2215
language English
last_indexed 2024-03-10T17:15:30Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Journal of Ovarian Research
spelling doaj.art-a46322bce85a47af9cadaa4ee4c2781e2023-11-20T10:32:33ZengBMCJournal of Ovarian Research1757-22152023-08-011611610.1186/s13048-023-01251-wEffect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimestersNarjes Hassan Haivadi0Shahideh Jahanian Sadatmahalleh1Fatemeh Razavinia2Sarang Younesi3Malihe Nasiri4Saeideh Ziaei5Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Midwifery, School of Nursing & Midwifery, Ahvaz Jundishapur University of Medical SciencesNilou Medical LaboratoryDepartment of Basic Sciences, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical SciencesDepartment of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares UniversityAbstract Background Polycystic ovary syndrome (PCOS) is characterized by insulin resistance and hormonal disorder in women. This study aimed to assess the effect of maternal PCOS on screening of aneuploidy in the first and second-trimesters. Methods This case-control study was conducted in Arash Hospital and Nilou Laboratory in 2017–2018. The screening test was conducted on 90 PCOS and 90 healthy mothers. Finally, the first and second-trimester screening was compared between the two groups using Chi-square, Mann-Whitney’s U and students T tests and regression model by SPSS 21. P < 0.05 was considered as statistically significant. Results Free Beta-Human Chorionic Gonadotropin (Free-β-HCG) (P = 0.04), inhibin-A (P = 0.001) and Alpha Fetoprotein (AFP) (P = 0.02) levels were higher in the PCOS women comparing to the healthy women but there was no significant difference between the mean of HCG, Plasma Protein A (PAPP-A), and Unconjugated Estriol (UE3) between the two groups. Pre-eclampsia (P < 0.001) and trisomy 18 risks in quad screening were higher in the PCOS women (P = 0.002) than the control group; however, trisomy 13, trisomy 18 and trisomy 21 risks, Smith-Lemli-Opitz Syndrome (SLOS) and Neural Tube Defect (NTD) risks were not different between the two groups. The logistic regression model showed that the first- and second-trimester screening of aneuploidywas related to PCOS. Conclusions There was a significant difference in the mean of free-β-HCG, inhibin-A, AFP level, and the risks of pre-eclampsia, SLOS and trisomy 18 between the two groups but no significant association was found in the mean of HCG, PAPP-A, UE3, NTD and other aneuploidies between the two groups. PCOS may affect the first- and second-trimester screening tests and pregnancy health. It may also require correction in the calculation of risks related to the first- and second-trimester screening for aneuploidy.https://doi.org/10.1186/s13048-023-01251-wPolycystic ovary syndromeFirst-trimester screening testSecond-trimester screening testAneuploidy
spellingShingle Narjes Hassan Haivadi
Shahideh Jahanian Sadatmahalleh
Fatemeh Razavinia
Sarang Younesi
Malihe Nasiri
Saeideh Ziaei
Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
Journal of Ovarian Research
Polycystic ovary syndrome
First-trimester screening test
Second-trimester screening test
Aneuploidy
title Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
title_full Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
title_fullStr Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
title_full_unstemmed Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
title_short Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters
title_sort effect of maternal polycystic ovary syndrome pcos on screening of aneuploidy in the first and second trimesters
topic Polycystic ovary syndrome
First-trimester screening test
Second-trimester screening test
Aneuploidy
url https://doi.org/10.1186/s13048-023-01251-w
work_keys_str_mv AT narjeshassanhaivadi effectofmaternalpolycysticovarysyndromepcosonscreeningofaneuploidyinthefirstandsecondtrimesters
AT shahidehjahaniansadatmahalleh effectofmaternalpolycysticovarysyndromepcosonscreeningofaneuploidyinthefirstandsecondtrimesters
AT fatemehrazavinia effectofmaternalpolycysticovarysyndromepcosonscreeningofaneuploidyinthefirstandsecondtrimesters
AT sarangyounesi effectofmaternalpolycysticovarysyndromepcosonscreeningofaneuploidyinthefirstandsecondtrimesters
AT malihenasiri effectofmaternalpolycysticovarysyndromepcosonscreeningofaneuploidyinthefirstandsecondtrimesters
AT saeidehziaei effectofmaternalpolycysticovarysyndromepcosonscreeningofaneuploidyinthefirstandsecondtrimesters